60 related articles for article (PubMed ID: 22239017)
1. Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma.
Lin W; Chen YL; Jiang L; Chen JK
Clin Lab; 2011; 57(11-12):879-85. PubMed ID: 22239017
[TBL] [Abstract][Full Text] [Related]
2. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma.
Imai K; Takai K; Hanai T; Shiraki M; Suzuki Y; Hayashi H; Naiki T; Nishigaki Y; Tomita E; Shimizu M; Moriwaki H
Int J Mol Sci; 2014 Jun; 15(7):11294-306. PubMed ID: 24968270
[TBL] [Abstract][Full Text] [Related]
3. Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study.
Wang C; Wu WK; Liu X; To KF; Chen GG; Yu J; Ng EK
Peptides; 2014 Jan; 51():131-8. PubMed ID: 24274970
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in mice.
Shi J; Zhu L; Tang BY; Yang WQ; Xi SY; Zhang CL; Li PF; Wang YJ; Guo KH; Huang JR; Huang CR; Yu ZX; Yu BK; Zhang CF; Zhang YM
J Nat Med; 2024 Jun; 78(3):633-643. PubMed ID: 38704807
[TBL] [Abstract][Full Text] [Related]
5. Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients.
Weber F; Utpatel K; Evert K; Treeck O; Buechler C
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979716
[TBL] [Abstract][Full Text] [Related]
6. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin.
Hu X; Xiang F; Feng Y; Gao F; Ge S; Wang C; Zhang X; Wang N
Front Oncol; 2022; 12():812044. PubMed ID: 35155249
[TBL] [Abstract][Full Text] [Related]
8. A Chemerin Peptide Analog Stimulates Tumor Growth in Two Xenograft Mouse Models of Human Colorectal Carcinoma.
Friebus-Kardash J; Schulz P; Reinicke S; Karthaus C; Schefer Q; Bandholtz S; Grötzinger C
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008289
[TBL] [Abstract][Full Text] [Related]
9. Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges.
Hao X; Sun G; Zhang Y; Kong X; Rong D; Song J; Tang W; Wang X
Front Cell Dev Biol; 2021; 9():775462. PubMed ID: 34869376
[TBL] [Abstract][Full Text] [Related]
10. The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis.
Dubois-Vedrenne I; Al Delbany D; De Henau O; Robert V; Vernimmen M; Langa F; Lefort A; Libert F; Wittamer V; Parmentier M
Oncotarget; 2021 Sep; 12(19):1903-1919. PubMed ID: 34548907
[TBL] [Abstract][Full Text] [Related]
11. New insight into long non-coding RNAs associated with bone metastasis of breast cancer based on an integrated analysis.
Zhang Y; Huang X; Liu J; Chen G; Liu C; Zhang S; Li J
Cancer Cell Int; 2021 Jul; 21(1):372. PubMed ID: 34256750
[TBL] [Abstract][Full Text] [Related]
12. The potential value of serum chemerin in patients with breast cancer.
Song Y; Zhu X; Lin Z; Luo L; Wen D
Sci Rep; 2021 Mar; 11(1):6564. PubMed ID: 33753802
[TBL] [Abstract][Full Text] [Related]
13. Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma.
Haberl EM; Feder S; Pohl R; Rein-Fischboeck L; Dürholz K; Eichelberger L; Wanninger J; Weiss TS; Buechler C
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066325
[TBL] [Abstract][Full Text] [Related]
14. A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer.
Huang C; Dai XY; Cai JX; Chen J; Wang BB; Zhu W; Wang E; Wei W; Zhang JV
Mol Ther Oncolytics; 2020 Sep; 18():602-612. PubMed ID: 33005727
[TBL] [Abstract][Full Text] [Related]
15. Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation.
Feder S; Bruckmann A; McMullen N; Sinal CJ; Buechler C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003572
[TBL] [Abstract][Full Text] [Related]
16. Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.
Kim H; Lee JH; Lee SK; Song NY; Son SH; Kim KR; Chung WY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325994
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bioactive Chemerin by Keratinocytes Inhibits Late Stages of Tumor Development in a Chemical Model of Skin Carcinogenesis.
Dubois-Vedrenne I; De Henau O; Robert V; Langa F; Javary J; Al Delbany D; Vosters O; Angelats-Canals E; Vernimmen M; Luangsay S; Wittamer V; Parmentier M
Front Oncol; 2019; 9():1253. PubMed ID: 31803622
[TBL] [Abstract][Full Text] [Related]
19. More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.
Goralski KB; Jackson AE; McKeown BT; Sinal CJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561459
[TBL] [Abstract][Full Text] [Related]
20. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma.
Feder S; Kandulski A; Schacherer D; Weiss TS; Buechler C
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31409008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
